コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 vere thyroid hormone deficiency and profound hearing impairment.
2 135G>T [p.Glu379X]) in ILDR1 as the cause of hearing impairment.
3 rlying nonsyndromic prelingual sensorineural hearing impairment.
4 of the mechanisms of hypothyroidism-induced hearing impairment.
5 sleep deprivation, immobility and visual and hearing impairment.
6 th an increased risk of substantial neonatal hearing impairment.
7 ner ear histology suggestive of a conductive hearing impairment.
8 l hearing and 7 with bilateral sensorineural hearing impairment.
9 e unit (NICU), and one of them had bilateral hearing impairment.
10 thyroid hormone dysregulation in age-related hearing impairment.
11 vating neurons is the most frequent cause of hearing impairment.
12 d neural system of the inner ear, leading to hearing impairment.
13 nd travel, among individuals who also have a hearing impairment.
14 t heterozygous mice do not suffer peripheral hearing impairment.
15 d with a higher likelihood of developing any hearing impairment.
16 molecular mechanisms underlying hearing and hearing impairment.
17 autosomal dominant, nonsyndromic hereditary hearing impairment.
18 universal neonatal screening programmes for hearing impairment.
19 egated with the inherited autosomal dominant hearing impairment.
20 a conditioning tone, perhaps attributable to hearing impairment.
21 at least 30 autosomal loci for nonsyndromic hearing impairment.
22 vement in immobility, visual impairment, and hearing impairment.
23 sclerosis is the single most common cause of hearing impairment.
24 ry disorder that causes hypopigmentation and hearing impairment.
25 0 of these children have moderate or greater hearing impairment.
26 RP) with or without congenital sensorineural hearing impairment.
27 CNS mechanisms are affected by a peripheral hearing impairment.
28 ese myosins in patients suffering visual and hearing impairment.
29 icity in the perceptual sequelae of cochlear hearing impairment.
30 gic disease, brain lesions, drug effect, and hearing impairment.
31 uced myelination might augment sensorineural hearing impairment.
32 ptors of the auditory system re-emerges with hearing impairment.
33 ign of damage in both noise- and age-related hearing impairment.
34 oaches and medical care for LF patients with hearing impairment.
35 r, and prognostic indicator, for age-related hearing impairment.
36 , indicating hair cell dysfunction and gross hearing impairment.
37 in a socially excluded group of people with hearing impairment.
38 examined a clinical cohort of subjects with hearing impairment.
39 tation had symmetric, mild-to-moderate mixed hearing impairment.
40 isk for psychosis is observed in people with hearing impairment.
41 idneys, diabetes, hepatitis, depression, and hearing impairment.
42 ty of a link between K(v)1.1 dysfunction and hearing impairment.
43 normal hearing listeners and other forms of hearing impairment.
44 within 19 genetic intervals associated with hearing impairment.
45 or a substantial proportion of patients with hearing impairment.
46 studies in older humans when controlling for hearing impairments.
47 s that cause severe prelingual non-syndromic hearing impairments.
48 e fibers, can lead to profound and permanent hearing impairments.
49 r diagnosis of cerebral palsy and visual and hearing impairments.
50 00), IGF-1 was associated with lower odds of hearing impairment (0.86; 0.73, 1.00) after adjustment f
51 he appropriate compensation of sensorineural hearing impairment across a range of frequencies (e.g.,
52 ous for KARS mutations had symmetric, severe hearing impairment across all frequencies but did not sh
53 family with autosomal dominant nonsyndromic hearing impairment (ADNSHI) was enrolled in this study.
55 ter than the effects of vision impairment or hearing impairment alone, because when these two sensory
57 protective effects on hypothyroidism-induced hearing impairment, an F1 intercross was generated betwe
58 n leads to the DFNA17 phenotype (progressive hearing impairment and cochleosaccular degeneration) rem
59 uated and considered in future management of hearing impairment and design of auditory prostheses.
62 ion are advancing molecular understanding of hearing impairment and the complex mechanisms of the aud
63 screening for permanent bilateral childhood hearing impairment and the effects of confirmation of he
66 search tool that can elucidate the nature of hearing impairments and suggest or eliminate compensator
70 children aged 6-19 years have some degree of hearing impairment, and over 216,000 of these children h
72 iovascular disease, itself a risk factor for hearing impairment, and, in animal studies, molecular ev
73 a range of adverse listening conditions and hearing impairments, and even for users of cochlear impl
78 damage to the inner ear is a major cause of hearing impairment, arising from exposures occurring dur
80 ciated with autosomal-recessive nonsyndromic hearing impairment (ARNSHI), was mapped to chromosomal r
81 e to the aetiology of amblyaudia, a binaural hearing impairment associated with bouts of otitis media
83 formation of the heart and other organs, and hearing impairment associated with recurrent ear infecti
86 mpairment and the effects of confirmation of hearing impairment by nine months of age on subsequent v
89 family members in three generations: 10 with hearing impairment caused by the DFNA23 locus, 8 unaffec
91 ogical abnormalities of the external ear and hearing impairment (conductive or sensorineural) affect
92 fects, but three of 11 surviving infants had hearing impairment confirmed on auditory testing between
93 as immobility, functional decline, visual or hearing impairment, dehydration, and sleep deprivation a
95 have been linked to non-syndromic hereditary hearing impairment DFNA17 as well as 'MYH9-related disea
96 me type IB, autosomal-recessive nonsyndromic hearing impairment (DFNB2), and autosomal-dominant nonsy
98 ice, in contrast, present with non-syndromic hearing impairment due to the effects of multiple genes
101 holistic approaches to health management and hearing impairment, (f) universal access to evolving and
102 iption cofactor Eyes absent 4 (Eya4), causes hearing impairment followed by dilative cardiomyopathy.
103 US population, and prevalences of vision and hearing impairment have been extensively evaluated.
106 #267300) often associated with sensorineural hearing impairment; however, mice with a knockout mutati
107 ry, smoking, body mass index, and vision and hearing impairment (HR = 1.05, 95% CI = 1.03-1.07, p < 0
108 tudied 120 children with bilateral permanent hearing impairment identified from a large birth cohort
109 reduced hearing ability and the duration of hearing impairment in 42 unilateral hearing loss (UHL) p
110 0 on screening for age-related sensorineural hearing impairment in adults aged 50 years or older with
113 The condition began with high-frequency hearing impairment in all family members excluding III:2
114 effect of birth cohort on the prevalence of hearing impairment in an adult population aged 45-94 yea
115 tations in the POU domain gene Brn-3c causes hearing impairment in both the human and mouse as a resu
120 iants co-segregates with congenital profound hearing impairment in consanguineous Pakistani families
123 icate that the short nose, otitis media, and hearing impairment in Jacobsen syndrome are likely becau
128 1 appeared to confer some protection against hearing impairment in some older adults warrants replica
131 o national guidelines, and the prevalence of hearing impairment in the two groups was compared by usi
133 amily with X-linked postlingual nonsyndromic hearing impairment in which the critical linkage interva
134 the genetic and physiological bases of human hearing impairment, including both early- and late-onset
135 a range of adverse listening conditions and hearing impairments, including cochlear implant-supporte
136 , TR beta 2-null mice exhibit no evidence of hearing impairment, indicating that TR beta 1 and TR bet
138 Given that the frequency of all childhood hearing impairment is 1/1,000 and that half of that is g
147 genetic deafness is non-syndromic, in which hearing impairment is not associated with any other abno
149 mporal resolution in listeners with cochlear hearing impairment is presented with the aim of assessin
150 autosomal dominant late-onset non-syndromic hearing impairment is segregating, we have identified a
156 the link between IGF-1 and the occurrence of hearing impairment is untested in population-based studi
157 ied mutation in CABP2 that causes a moderate hearing impairment likely via nonsense-mediated decay of
158 y, a novel autosomal recessive non-syndromic hearing impairment locus DFNB44 was mapped to chromosome
159 generation and a moderate but nonprogressive hearing impairment, mimicking the visual and hearing def
160 for blindness (0.9% vs 0%; P = .02), and for hearing impairment (moderate and severe, 0.9% vs 0%; P =
161 sifiable category where 67.2% had documented hearing impairment, more than in any other group (P < 0.
162 benefit to individuals in all categories of hearing impairment (normal, mild, moderate, severe, and
165 ho had confirmed bilateral OME and bilateral hearing impairment of 25-70 dB of at least 3 months' dur
167 y, age-adjusted prevalence of high-frequency hearing impairment of mild or greater severity in the wo
168 adjusted prevalence of low- or mid-frequency hearing impairment of mild or greater severity in the wo
170 uditory hair cell defect is a major cause of hearing impairment, often leading to spiral ganglia neur
171 uditory brainstem responses indicated a mild hearing impairment on hair cell-specific deletion of all
174 85); deafness (OR, 2.19; 95% CI, 1.17-4.12); hearing impairment (OR,1.55; 95% CI, 1.29-1.87); upper e
175 tory factors such as neurological disorders, hearing impairment, or lack of adequate opportunity-are
177 rt, IGF-1 was not associated with subsequent hearing impairment (OR5nmol/L increase; 95% CI: 1.01; 0.
179 , personal or parental history of migration, hearing impairment, parental age, parental income, paren
180 ement for infants with a permanent childhood hearing impairment (PCHI) during 2011-2015 at a U.K. ser
181 born screening (UNS) for permanent childhood hearing impairment (PCHI) was undertaken to establish wh
182 riants both segregated with the nonsyndromic-hearing-impairment phenotype within the three families,
183 ost common sensory disorder, with congenital hearing impairment present in approximately 1 in 1,000 n
186 e brain revealed a significant enrichment of hearing impairment-related oligos in the SOC (26 in the
187 ents surviving BTs were at elevated risk for hearing impairments (relative risk [RR], 17.3; P = <.000
188 ad an increased risk of exacerbations but no hearing impairment, resting tachycardia, or apparent ris
191 nt was independent of known risk factors for hearing impairment, such as noise exposure, ototoxic med
192 he acoustic startle response consistent with hearing impairment, suggesting a novel role for Rsph9 in
193 lying neurodegenerative disorder or isolated hearing impairment tended to hear more persistent music,
194 ently believed to be permanent, resulting in hearing impairment that affects more than 10% of the pop
195 air cell survival and therefore minimize the hearing impairment that normally occurs with aging and/o
196 with universal newborn screening and 57 had hearing impairment that was confirmed by nine months of
197 Tecta domains causing mid- or high-frequency hearing impairments that are either stable or progressiv
198 e been linked to the most frequent monogenic hearing impairment, the recessive isolated deafness DFNB
199 th a relative frequency greater than 4% were hearing impairment (three [3%] of 93 patients in the SRS
213 hildren and 0.0% of controls (P < .001), and hearing impairment was observed in 2.1% of extremely pre
214 for low- or mid-frequency and high-frequency hearing impairment were 1.82 [CI, 1.27 to 2.60] and 2.16
215 r increase in birth year, the odds of having hearing impairment were 13% lower in men (odds ratio = 0
217 of the baseline scores paralleled degree of hearing impairment when impairment was defined using a b
218 t at 4 weeks most showed variable degrees of hearing impairment, which became severe or profound in a
219 Four subjects from three families reported hearing impairment, which has not previously been report
220 Atp6v1b1vtx/vtx mutant mice exhibit profound hearing impairment, which is associated with enlarged en
221 fferent types of gene products can result in hearing impairment, which, given the complexity of the a
222 This stop-gained mutation segregated with hearing impairment within the family and was not identif
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。